Opportunities
Search

Buyer: Stichting Yuverta | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-14

Buyer: Gemeente Hardenberg | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-14

Buyer: AYUNTAMIENTO DE L'ELIANA | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-09-14

Buyer: Gemeente Hardenberg | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Politie | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-14

Buyer: Chemins de fer fédéraux suisses CFF, Infrastructure – Achats, Supply Chain et production, Achats projets de construction Région Centre | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Eskilstuna kommun | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Region Stockholm - Förvaltning för utbyggd tunnelbana | Notice type: cn-standard | Procedure: neg-w-call | Contract: works | Deadline: 2026-09-14

Buyer: Metropole Toulon-Provence-Mediterranee | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-14

Buyer: Gemeente Velsen | Notice type: pin-rtl | Procedure: open | Contract: services | Deadline: 2026-09-14

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as Director and Deputy Director of the Neurofibromatosis Research Academy. The Academy Director and Deputy Director will execute a multi-institutional, interactive, virtual research academy that consists of scholars, who are early-career investigators, and their career guides, who serve as the scholars’ primary mentors.Distinctive Features:• Academy Director: Established NF investigators at or above the level of Associate Professor, or equivalent, at the full application submission deadline.• Academy Deputy Director: Investigators at or above the level of Associate Professor, or equivalent, at the full application deadline and affiliated with a different institution than the Academy Director.• Pilot Research Project: The Academy Director and Deputy Director will conduct one or more pilot research projects in collaboration with the academy scholars. Preliminary and/or published data relevant to NF and the proposed research project are encouraged but not required.

Expected Outcome:Activities under this topic respond directly to the goal of the Mission Soil to set up 100 living labs and lighthouses to lead the transition to healthy soils by 2030 and support the specific objectives of the Mission Soil.Activities should also contribute to the Common Agricultural Policy, and to meeting the European Green Deal ambitions and targets and more specifically those of the EU Biodiversity Strategy for 2030, the EU soil strategy for 2030 and the proposal for a Soil Monitoring and Resilience Directive, the Zero Pollution Action Plan, the EU Forest Strategy, as well as to the Sustainable Development Goals[1].Project results are expected to contribute to all the following expected outcomes:enhanced capacities for participatory, interdisciplinary and transdisciplinary R&I to co-create, and co-implement economically viable soil health solutions tailored to managed...

Expected Outcome:Activities under this topic respond directly to the goal of the Mission Soil to set up 100 living labs and lighthouses to lead the transition to healthy soils by 2030. They support the specific objectives of the Mission Soil[1]. Activities should also contribute to the Common Agricultural Policy and to meeting the European Green Deal ambitions and targets and more specifically those of the EU Biodiversity Strategy for 2030, the EU Soil Strategy for 2030 and the proposal for a Soil Monitoring and Resilience Directive, the Zero Pollution Action Plan, the Communication on Boosting Biotechnology and Biomanufacturing in the EU, as well as to Sustainable Development Goals[2].Project results are expected to contribute to all the following expected outcomes:enhanced capacities for participatory, interdisciplinary and transdisciplinary R&I to co-create and co-implement economical...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:the EU strategic autonomy and the long-term sustainability of EU farming systems are safeguarded;farmers benefit from new knowledge, innovations and practices to make the green transition towards sustainable and biodiversity friendly agriculture. Scope:EU farmers face numerous competitiveness challenges. According to a study by the EP[1], the growth of total factor productivity (TFP) in EU agriculture has been slowing down while some of our competitors, like Brazil, Canada and China, show higher TFP growth. In order to revert this trend, improving the efficiency of the production factors is a possible avenue, while at the same time considering its sustainable use. Proposals should address all the following activities:develop prototypes of innovations and farming practices that can improv...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:farmers, advisors, agri-food chain operators, policy-makers, public funders and citizens benefit from new knowledge and knowledge exchange, viable innovations, practices and tools that boost the competitiveness, sustainability (economic, environmental, social) and resilience of the organic farming sector;knowledge and innovations contribute to an improved sustainability of organic farming systems and an overall improved efficiency of the sector, leading to an increased attractiveness of organic farming in Europe and an improved understanding of its contribution to sustainability (economic, social, biodiversity, climate);the EU regulatory framework for organic farming, the Common Agricultural Policy, and the EU’s biodiversity, zero pollution and climate policies are supported by science-b...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Healthy people and in particular people at risk will benefit from microbiome tests and programmes that can discover and predict their transition to cancer before the onset of disease.People will have a better understanding of risks and will be enabled to address risks early by following treatments or adapting their lifestyles, including nutrition and other interventions.Physicians will be able to start cancer treatments earlier with a higher success rate.Policy makers and authorities will be enabled to develop and implement advanced and strategic programmes addressing cancer prevention. Scope:This topic will contribute to the achievement of the EU Cancer Mission’s objective to achieve better cancer prevention and early d...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:Improved understanding of care needs of older patients with cancer and approaches to address them;Older cancer patients gain access to innovative age-specific approaches and tools better tailored to their care needs;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to implement tailored care for older cancer patients that have the potential to be implemented in routine treatment and follow-up care in their healthcare systems; Scope:This topic contributes to the EU Cancer Mission’s objective to improve quality of life of cancer patients. The focus is on cancer patients aged 65 years and above.Currently, older cancer patients represent the...

Expected Outcome:This topic aims to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care.To this end, proposals should aim at delivering results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers, clinicians and health care professionals will have access to improved research capacities, supporting better integration with care.Patients and citizens will have access to improved screening, diagnostics and treatments, while increasing their participation in clinical trials. Scope:Ukraine has a very high cancer burden with more than 155,000 new diagnoses every year[1]. The country has also one of the highest childhood cancer mortality rates globally[2]. Dispa...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Patients with refractory cancers and their caregivers/families will have access to optimised, tailored and affordable immunotherapeutic interventions that increase their quality of life, across European regions, EU Member States and Associated Countries;Healthcare professionals and academia will have access to clinical evidence, on effectiveness of immunotherapeutic interventions, to deploy evidence-based treatment interventions with improved patient selection that improve outcomes in real life, i.e. in routine healthcare, for patients with refractory cancers who often present with co-morbidities;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries wil...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers of different disciplines use advanced multiscale Virtual Human Twins (VHTs) to expand the knowledge and understanding of cancer onset and progressionHealthcare professionals and researchers have access to advanced VHT-based solutions that model cancer onset and progression over time, contributing to improve personalised treatmentsResearchers, healthcare professionals, innovators and citizens have access to cancer VHTs through the UNCAN.eu and the advanced Virtual Human Twin platforms Scope:Virtual human twins (VHTs) are digital representations and in-silico models of an individual’s health and disease at different levels of the human anatomy (e.g. cells, tissues, organs or organ systems) for the prevention, p...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Patients will benefit from better access to earlier, more person-centred palliative care models including digital remote tools and options for home-based care.Carers will benefit from real-time information tools and better communication.Clinicians will benefit from guidelines on optimal patient referral and care predictions. Scope:This topic will contribute to the achievement of the EU Cancer Mission’s objective to provide better quality of life for cancer patients, their families and carers. The focus is on the development of innovative models for earlier, more precise and better integrated palliative care.According to an EU conference on innovative palliative care for people with cancer on 8 October 2024[1], palliative...

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to the following expected outcomes:Through the European Cancer Patient Digital Centre (ECPDC), adolescent and young cancer patients and survivors as well as their caregivers have access to innovative tools and approaches to strengthen their mental health;Healthcare professionals have access to innovative tools to monitor and support the mental health of cancer patients and survivors as well as their caregiversResearchers and healthcare professionals have access and use reliable patient reported data to better understand the mental health needs of cancer patients and survivors and provide effective care. Scope:As part of its citizens engagement activities, the EU Cancer Mission has launched a dialogue with young cancer survivors, to better understand the specific...

Scope:Topic scope:Raising awareness of and building capacity for the EU Charter of Fundamental Rights (CERV-2026-CHAR-LITI-CHARTER)The Charter strategy underlines the importance of strengthening the application of the Charter through awareness raising and capacity building initiatives. Accordingly, projects under this priority are intended to raise the fundamental rights knowledge of relevant actors. While building on the central role of civil society organisations and human rights defenders, funded projects could involve national, regional and local authorities as partners (co-applicants), with the aim of supporting joint capacity building and awareness raising efforts.The projects funded under this priority should address the capacity building and awareness raising needs on the Charter. In particular, relevant projects should focus on raising awareness and building capacity on at least...

Scope:Topic scope:Promoting an enabling civic space (CERV-2026-CHAR-LITI-CIVIC)A thriving civic space requires an enabling legal, administrative and regulatory environment in which civil society organisations (CSOs) are supported and empowered, protected from threats, and able to operate freely. This call therefore aims to reinforce the conditions for such an environment by supporting actions that strengthen both the monitoring of civic space and the protection and resilience of CSOs and human rights defenders working to uphold EU values. Monitoring of civic spaceProjects should establish or enhance systematic and comprehensive monitoring systems to regularly assess the environment in which CSOs operate at national level. These should build on and align as closely as possible with existing frameworks—such as the indicators developed by the European Union Agency for Fundamental Rights and...

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The EU is reinforced as an internationally recognised driver of research and innovation in Rare Diseases (RD) and thereby substantially contributing to the achievement of the Sustainable Development Goals related to rare diseases.Research funders align, adopt and implement their RD research policies allowing for the optimal generation and translation of knowledge into meaningful health products and interventions responding to the needs of people living with a rare disease across Europe and globally.The RD research community at large benef...